Ross Muken
Stock Analyst at Evercore ISI Group
(2.51)
# 2,270
Out of 5,240 analysts
50
Total ratings
58.62%
Success rate
0.42%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ross Muken
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: Outperform | $200 → $220 | $162.85 | +35.09% | 12 | May 8, 2026 | |
| HSIC Henry Schein | Maintains: In-Line | $78 → $70 | $69.45 | +0.79% | 10 | Aug 6, 2025 | |
| ICLR ICON Public Limited Company | Maintains: Outperform | $170 → $240 | $117.38 | +104.46% | 9 | Jul 25, 2025 | |
| A Agilent Technologies | Maintains: In-Line | $126 → $130 | $112.74 | +15.31% | 11 | Jul 2, 2024 | |
| QGEN Qiagen | Downgrades: In-Line | n/a | $32.70 | - | 2 | Jul 16, 2019 | |
| CAH Cardinal Health | Initiates: In-Line | $67 | $186.35 | -64.05% | 2 | Jan 5, 2018 | |
| ILMN Illumina | Initiates: Outperform | $250 | $145.00 | +72.41% | 2 | Jan 4, 2018 | |
| TMO Thermo Fisher Scientific | Initiates: Outperform | $220 | $446.03 | -50.68% | 1 | Jan 4, 2018 | |
| MBLY Mobileye Global | Downgrades: In-Line | n/a | $10.53 | - | 1 | Mar 13, 2017 |
Charles River Laboratories International
May 8, 2026
Maintains: Outperform
Price Target: $200 → $220
Current: $162.85
Upside: +35.09%
Henry Schein
Aug 6, 2025
Maintains: In-Line
Price Target: $78 → $70
Current: $69.45
Upside: +0.79%
ICON Public Limited Company
Jul 25, 2025
Maintains: Outperform
Price Target: $170 → $240
Current: $117.38
Upside: +104.46%
Agilent Technologies
Jul 2, 2024
Maintains: In-Line
Price Target: $126 → $130
Current: $112.74
Upside: +15.31%
Qiagen
Jul 16, 2019
Downgrades: In-Line
Price Target: n/a
Current: $32.70
Upside: -
Cardinal Health
Jan 5, 2018
Initiates: In-Line
Price Target: $67
Current: $186.35
Upside: -64.05%
Illumina
Jan 4, 2018
Initiates: Outperform
Price Target: $250
Current: $145.00
Upside: +72.41%
Thermo Fisher Scientific
Jan 4, 2018
Initiates: Outperform
Price Target: $220
Current: $446.03
Upside: -50.68%
Mobileye Global
Mar 13, 2017
Downgrades: In-Line
Price Target: n/a
Current: $10.53
Upside: -